John W. R. Kincaid

John W. R. Kincaid

Auto-generated profile, based on publicly available information

John W. R. Kincaid

M. Nguyen is an MD/PhD candidate, Yale School of Medicine, New Haven, Connecticut; ORCID: https://orcid.org/

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 January 2024 in Scientific Reports
Verified
Journal Article
Open access
PDF file
JKJohn W. R. Kincaid
John W. R. Kincaid
DRDebra Rimmington
Debra Rimmington
JTJohn A. Tadross
John A. Tadross
ICIrene Cimino
Irene Cimino
IZIlona Zvetkova
Ilona Zvetkova
ACAnthony P. Coll
Anthony P. Coll
The hormone GDF15 is secreted in response to cellular stressors. Metformin elevates circulating levels of GDF15, an action important for the drug’s beneficial effects on body weight. Metformin can also inhibit mammalian respiratory complex I, leading to decreases in ATP:AMP ratio, activation of AMP Kinase (AMPK), and increased GDF15 production. We undertook studies using a range of mice with tissue-specific loss of Gdf15 (namely gut, liver and global deletion) to determine the relative contributions of two classical metformin target tissues, the gut and liver, to the elevation of GDF15 seen with metformin. In addition, we performed comparative studies with another pharmacological agent, the AMP kinase pan-activator, MK-8722. Deletion of Gdf15 from the intestinal epithelium significantly reduced the circulating GDF15 response to oral metformin, whereas deletion of Gdf15 from the liver had no effect. In contrast, deletion of Gdf15 from the liver, but not the gut, markedly reduced circulating GDF15 responses to MK-8722. Further, our data show that, while GDF15 restricts high-fat diet-induced weight gain, the intestinal production of GDF15 is not necessary for this effect. These findings add to the body of evidence implicating the intestinal epithelium in key aspects of the pharmacology of metformin action.

20 June 2023 in The Journal of Clinical Endocrinology & Metabolism
Verified
Journal Article
Open access
PDF file
KDKatie Duckett
Katie Duckett
AWAlice Williamson
Alice Williamson
JKJohn W R Kincaid
John W R Kincaid
KRKara Rainbow
Kara Rainbow
LCLaura Corbin
Laura Corbin
SOStephen O’rAhilly
Stephen O’rAhilly
Context The melanocortin 3 receptor (MC3R) has recently emerged as a critical regulator of pubertal timing, linear growth, and the acquisition of lean mass in humans and mice. In population-based studies, heterozygous carriers of deleterious variants in MC3R report a later onset of puberty than noncarriers. However, the frequency of such variants in patients who present with clinical disorders of pubertal development is currently unknown. Objective This work aimed to determine whether deleterious MC3R variants are more frequently found in patients clinically presenting with constitutional delay of growth and puberty (CDGP) or normosmic idiopathic hypogonadotropic hypogonadism (nIHH). Methods We examined the sequence of MC3R in 362 adolescents with a clinical diagnosis of CDGP and 657 patients with nIHH, experimentally characterized the signaling properties of all nonsynonymous variants found and compared their frequency to that in 5774 controls from a population-based cohort. Additionally, we established the relative frequency of predicted deleterious variants in individuals with self-reported delayed vs normally timed menarche/voice-breaking in the UK Biobank cohort. Results MC3R loss-of-function variants were infrequent but overrepresented in patients with CDGP (8/362 [2.2%]; OR = 4.17; P = .001). There was no strong evidence of overrepresentation in patients with nIHH (4/657 [0.6%]; OR = 1.15; P = .779). In 246 328 women from the UK Biobank, predicted deleterious variants were more frequently found in those self-reporting delayed (aged ≥16 years) vs normal age at menarche (OR = 1.66; P = 3.90E-07). Conclusion We have found evidence that functionally damaging variants in MC3R are overrepresented in individuals with CDGP but are not a common cause of this phenotype.

27 November 2024 in Journal of the American Pharmacists Association
Verified
Journal Article
Closed access
JKJohn Kim
John Kim
JKJohn W.R. Kincaid
John W.R. Kincaid
ARArya S. Rao
Arya S. Rao
WLWinston Lie
Winston Lie
LFLanting Fuh
Lanting Fuh
MSMarc D. Succi
Marc D. Succi

21 October 2022 in Nature Reviews Endocrinology
Verified
Journal Article
Closed access
PDF file
JKJohn W. R. Kincaid
John W. R. Kincaid
ACAnthony P. Coll
Anthony P. Coll

24 June 2025 in Academic Medicine
Verified
Journal Article
Closed access
MNMytien Nguyen
Mytien Nguyen
BSBassel M. Shanab
Bassel M. Shanab
KKKhosla Khosla
Khosla Khosla
DBDowin Boatright
Dowin Boatright
SCSarwat I. Chaudhry
Sarwat I. Chaudhry
CLCindy Leung
Cindy Leung
Purpose: Food insecurity is negatively associated with college students’ well-being and academic performance. Little is known about the prevalence of food insecurity among medical students. This study examined variations in food insecurity among medical students at 15 schools, analyzing differences by disability status, race, ethnicity, and financial background. Method: Between March–October 2024, 1,659 students across 15 MD-granting medical schools completed an online survey. Over the past 12 months, food insecurity was assessed using the 10-item U.S. Household Food Security Survey Module. Additional survey measures included age, gender identity, race, ethnicity, Pell Grant recipient status, disability status, and graduation year. Poisson regression models were utilized to estimate the relative risk of food insecurity based on self-reported disability, race, ethnicity, and financial background and their intersections. Results: In the analytic sample, a higher proportion of students with disability (33.7% vs 21.8%, P <.001), from low-income backgrounds (34.9% vs 20.3%, P <.001), and those underrepresented in medicine (URiM) reported food insecurity (37.6% vs 19.7%, P <.001). Across intersectional groups, URiM low-income students with disability have the highest rate of food insecurity (62.5% vs 16.8% for nondisabled non-URiM non–low-income peers, P <.001). In the fully adjusted model, compared to nondisabled non-URiM non–low-income students, non-URiM and URiM low-income students with disability (non-URiM aRR: 2.44, 95% CI: 1.72–3.48; URiM aRR: 3.52, 95% CI: 2.79–4.45) had a higher relative risk of food insecurity. Conclusions: In this study, nearly 1 in 4 medical students were food insecure. URiM, low-income, and students with disabilities reported food insecurity at a significantly higher rate than their peers, with over half of URiM low-income students with disabilities reporting food insecurity. These findings suggest a promising yet underutilized avenue for approaches to enhancing well-being. Proactive efforts should prioritize supporting marginalized students by linking them to nutrition resources and advocating for policies that address their essential needs.

24 May 2022 in Obesity
Verified
Journal Article
Open access
JKJohn W. R. Kincaid
John W. R. Kincaid
GWGretchen Weiss
Gretchen Weiss
AHAnne E. Hill‐Baskin
Anne E. Hill‐Baskin
HSHeidi M. Schmidt
Heidi M. Schmidt
OOOvwoioise Omoijuanfo
Ovwoioise Omoijuanfo
Nathan BergerNathan Berger
Nathan Berger
Objective Obesity has emerged as a prominent risk factor for multiple serious disease states, including a variety of cancers, and is increasingly recognized as a primary contributor to preventable cancer risk. However, few studies of leukemia have been conducted in animal models of obesity. This study sought to characterize the impact of obesity, diet, and sex in a murine model of acute promyelocytic leukemia (APL). Methods Male and female C57BL/6J.mCG(+/PR) mice, genetically predisposed to sporadic APL development, and C57BL/6J (wild type) mice were placed on either a high-fat diet (HFD) or a low-fat diet (LFD) for up to 500 days. Results Relative to LFD-fed mice, HFD-fed animals displayed increased disease penetrance and shortened disease latency as indicated by accelerated disease onset. In addition, a diet-responsive sex difference in APL penetrance and incidence was identified, with LFD-fed male animals displaying increased penetrance and shortened latency relative to female counterparts. In contrast, both HFD-fed male and female mice displayed 100% disease penetrance and insignificant differences in disease latency, indicating that the sexual dimorphism was reduced through HFD feeding. Conclusions Obesity and obesogenic diet promote the development of APL in vivo, reducing sexual dimorphisms in disease latency and penetrance.